CD44 and neoplasm: Although Hermann et al. noted a 14% overlap among CD44+/CD24+/EpCAM+ and CD133+ cell populations in their pioneering study, this result was obtained in only one pancreatic cell line that was derived from a metastatic tumor and not from a primary tumor [4].